EpiBiologics | $107,000,000 | (Jan 9, 2026)
Corsera Health | $80,000,000 | (Jan 9, 2026)
Oasys | $4,600,000 | (Jan 9, 2026)
Certified by Founder
Lodge
DouxMatok
start up
Israel
- Petach-Tikva
- 24/05/2023
- Series C
- $30,000,000
We are on a mission to make the world a happier and healthier place. With the introduction of Incredo® Sugar, we can empower both delicious taste and improved nutrition, all while curbing the overconsumption of sugar.
- Industry Food and Beverage Services
- Website https://www.douxmatok.com/
- LinkedIn https://www.linkedin.com/company/douxmatok/
Related People
Eran BanielFounder
Israel -
ND
I’m often asked: how does a successful early career in show business tie in with founding and then successfully managing startup companies in CleanTech and other spaces? Insatiable curiosity, a passion to work with talented and innovative people and the challenging tasks of risk management are common to all the disciplines I’ve been fortunate to work in. Show biz has provided me with the tools that take complex ideas and inventions and make those accessible to people and to the relevant markets.
Vizgen | $48,000,000 | (Jan 9, 2026)
Poplar Therapeutics | $50,000,000 | (Jan 9, 2026)
Carna Health | $8,000,000 | (Jan 9, 2026)
Alveus Therapeutics Inc | $160,000,000 | (Jan 9, 2026)
AgileRL | $7,500,000 | (Jan 9, 2026)
Soley Therapeutics | $200,000,000 | (Jan 9, 2026)
SpangleAI | $15,000,000 | (Jan 9, 2026)
Presto Phoenix, Inc. | $10,000,000 | (Jan 9, 2026)
CHAMP | $55,000,000 | (Jan 7, 2026)